Related Experiment Video
Updated: Apr 25, 2026

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
Published on: July 12, 2021
Melatonin's Effect in Febrile Seizures and Epilepsy
Abolfazl Mahyar1, Parviz Ayazi1, Reza Dalirani2
1Department of Pediatrics, Qazvin University of Medical Sciences, Qazvin, Iran.
Insights
Serum melatonin levels show no association with febrile seizures (FS) or epilepsy in children. This study indicates melatonin does not play a significant role in these common childhood convulsive disorders.
Area of Science:
- Pediatric Neurology
- Endocrinology
- Convulsive Disorders
Background:
- Febrile seizures (FS) and epilepsy are common neurological conditions in children.
- Understanding risk factors for these disorders is crucial for effective management.
- The potential role of melatonin in convulsive disorders requires further investigation.
Purpose of the Study:
- To investigate the relationship between serum melatonin levels and febrile seizures (FS) in children.
- To determine if melatonin levels differ in children with epilepsy compared to controls.
- To assess the potential role of melatonin in the pathophysiology of FS and epilepsy.
Main Methods:
- A comparative study involving 111 children diagnosed with simple FS, complex FS, or epilepsy.
- A control group of 37 febrile children without seizures was included.
- Serum melatonin levels were quantified and compared across all study groups.
Main Results:
- Serum melatonin levels were comparable across groups: simple FS (2 pg/ml), complex FS (2.4 pg/ml), epilepsy (2 pg/ml), and controls (2.1 pg/ml).
- No statistically significant differences in serum melatonin levels were found between children with FS or epilepsy and the control group.
- Analysis revealed no significant variations when comparing the different case groups.
Conclusions:
- The study found no association between serum melatonin levels and the occurrence of simple or complex febrile seizures.
- Serum melatonin levels did not show a significant correlation with epilepsy in the pediatric population.
- Current evidence suggests melatonin does not play a significant role in the development or progression of these convulsive disorders.
Objective:
Recognition of risk factors for febrile seizures (FS) and epilepsy is essential. Studies regarding the role of melatonin in these convulsive disorders are limited. This study determines the relationship between serum melatonin levels and FS and epilepsy in children.
Materials & Methods:
A population of 111 children with simple FS, complex FS, and epilepsy (37 children per group, respectively) were included as case groups. In addition, 37 febrile children without seizures comprised the control group. Serum melatonin levels were measured and compared between all groups.
Results:
The serum melatonin levels in the simple, complex FSs, and epilepsy groups were 2, 2.4, and 2 pg/ml, respectively. The serum melatonin level in the control group was 2.1pg/ml. Moreover, there were no significant differences observed while comparing the case groups.
Conclusion:
The present study reveals that there is no association between serum melatonin level and simple or complex FS and epilepsy. It appears that melatonin plays no significant role in these convulsive disorders.
More Related Videos
09:06Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...